Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Blood

• Publication date

  2002-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V100.2.420PMID 12091331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

  2000cited by this paper
• Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.

  1999cited by this paper
• Med Pediatr Oncol

  1999cited by this paper
• Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.

  1998cited by this paper
• Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.

  1998cited by this paper
• Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.

  1997cited by this paper
• Uniform criteria for childhood acute lymphoblastic leukemia risk classification.

  1996influential reference
• Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

  1995cited by this paper
• Good steroid response in vivo predicts a favorable outcome in children with T‐cell acute lymphoblastic leukemia

  1995cited by this paper
• Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.

  1995cited by this paper
• Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.

  1994cited by this paper
• Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

  1993cited by this paper
• Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group.

  1993cited by this paper
• Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group.

  1992cited by this paper
• Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.

  1991cited by this paper
• [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].

  1987cited by this paper
• Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83)

  1987cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976influential reference
• Regression models and life tables (with discussion

  1972influential reference

• Results in pediatric T‐ALL patients treated in trial AIEOP‐BFM ALL 2009: Prognostic factors in the context of modern risk‐adapted therapy

  2025cites this paper
• Sleep Disturbances in Survivors of Childhood Acute Lymphoblastic Leukemia: A Cross-Sectional Study

  2025cites this paper
• Psychiatric Disorders in Survivors of Pediatric Acute Lymphoblastic Leukemia in India.

  2025cites this paper
• Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia

  2022cites this paper
• Efficacy and toxicity of high‐risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia

  2021cites this paper
• Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

  2021cites this paper
• Association of three factors (ABCB1 gene expression, steroid response, early response at day + 8) on the response to induction in patients with acute lymphoblastic leukemia

  2020cites this paper
• Leukemia stem cells promote chemoresistance by inducing downregulation of lumican in mesenchymal stem cells.

  2019cites this paper
• Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial

  2019cites this paper
• A JOINPOINT REGRESSION ANALYSIS OF LONG-TERM TRENDS IN LEUKEMIA INCIDENCE AND MORTALITY IN CENTRAL SERBIA AND NIŠAVA DISTRICT (1999-2014)

  2019cites this paper
• Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia

  2018cites this paper
• Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.

  2018cites this paper
• Impact of an animal-assisted therapy programme on physiological and psychosocial variables of paediatric oncology patients

  2018cites this paper
• Treatment of childhood acute lymphoblastic leukemia in Jakarta: Result of modified Indonesian National Protocol 94

  2016cites this paper
• Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Children

  2016cites this paper
• Treatment of acute lymphoblastic leukemia in children: a review of literature

  2016cites this paper
• Treatment of children with acute lymphoblastic leukemia with risk group based intensification and omission of cranial irradiation: A Korean study of 295 patients

  2016cites this paper
• Outcome of Children with Standard‐Risk T‐Lineage Acute Lymphoblastic Leukemia—Comparison among Different Treatment Strategies

  2016cites this paper
• Bone Marrow Transplantation in Patients with Acute Lymphoblastic Leukemia with Extremely Poor Prognosis: Literature Review and Case Report

  2015cites this paper
• Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.

  2014cites this paper
• Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study.

  2014cites this paper
• Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: Biology, Indications, and Outcomes

  2014cites this paper
• No impact of high‐dose cytarabine and asparaginase as early intensification with intermediate‐risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99‐15

  2014cites this paper
• Key Treatment Questions in Childhood Acute Lymphoblastic Leukemia: Results in 5 Consecutive Trials Performed by the ALL-BFM Study Group From 1981 to 2000

  2013cites this paper
• Flow cytometric chemosensitivity assay using JC-1, a sensor of mitochondrial transmembrane potential, in acute leukemia

  2013cites this paper
• Genetic Markers in the Prognosis of Childhood Acute Lymphoblastic Leukemia

  2013cites this paper
• SIL-TAL1 Rearrangement is Related with Poor Outcome: A Study from a Chinese Institution

  2013cites this paper
• Hematopoietic stem cell transplantation for children with high-risk acute lymphoblastic leukemia in first complete remission: a report from the AIEOP registry

  2013cites this paper
• childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study Late MRD response determines relapse risk overall and in subsets of

  2013cites this paper
• High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation

  2013cites this paper
• Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia

  2013cites this paper
• Outcomes after induction failure in childhood acute lymphoblastic leukemia.

  2012cites this paper
• Porównanie wyników leczenia u dzieci z ostrą białaczką limfoblastyczną leczonych w latach 1994–2001 i 2002–2007

  2012influential citation
• High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

  2011cites this paper
• [Results of treatment of acute lymphoblastic leukemia in two cohorts of Mexican patients].

  2011cites this paper
• Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.

  2011cites this paper
• Precocious puberty and empty sella syndrome in a girl cured of acute lymphoblastic leukemia

  2011cites this paper
• Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia: Current Treatment Status and Perspectives

  2011cites this paper
• Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia

  2010cites this paper
• Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.

  2010cites this paper
• Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

  2010cites this paper
• Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia Study (JACLS) ALL F‐protocol

  2010cites this paper
• Use of clofarabine for acute childhood leukemia

  2010cites this paper
• Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia

  2010cites this paper
• leukemia : results in 3184 patients of the AIEOP-BFM ALL 2000 study children and adolescents with B-cell precursor acute lymphoblastic Molecular response to treatment redefines all prognostic factors in

  2010cites this paper
• Extended triple intrathecal therapy in children with T‐cell acute lymphoblastic leukaemia: a report from the Israeli National ALL‐Studies

  2009influential citation
• High‐risk childhood acute lymphoblastic leukemia in China: Factors influencing the treatment and outcome

  2009cites this paper
• An open-label study to evaluate the safety and efficacy of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+ acute lymphoblastic leukemia (Ph+ALL)

  2009cites this paper
• Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

  2008cites this paper
• Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children’s Cancer Study Group Study L99-15

  2008cites this paper
• Oncogenes and prognosis in childhood T-cell acute lymphoblastic leukaemia

  2008cites this paper
• Treatment of acute lymphoblastic leukemia in children and adolescents: peaks and pitfalls.

  2008cites this paper
• Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

  2008cites this paper
• Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.

  2008cites this paper
• Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.

  2008cites this paper
• Treatment of pediatric acute lymphoblastic leukemia

  2008cites this paper
• Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.

  2008cites this paper
• The Impact of Acute Lymphoblastic Leukemia Treatment on Central Nervous System Results in Bogota, Colombia

  2008cites this paper
• Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

  2007cites this paper
• Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now?

  2007cites this paper
• Transplantation in Childhood Very High Risk Acute Lymphoblastic Leukemia in First Complete Remission: Where Are We Now?

  2007cites this paper
• Potential of Gene Expression Profiling in the Management of Childhood Acute Lymphoblastic Leukemia

  2007cites this paper
• Prognostic Significance of Molecular Follow-up by Qualitative and Real-Time Quantitative Reverse-Transcriptase Polymerase Chain Reaction in TEL/AML1–Positive Childhood Acute Lymphoblastic Leukemia

  2007cites this paper
• Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.

  2006cites this paper
• Infant leukaemia: clinical, biological and therapeutic advances.

  2006cites this paper
• Improved outcome of acute lymphoblastic leukaemia treated by delayed intensification in Hong Kong children: HKALL97 study.

  2006cites this paper
• Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.

  2006cites this paper
• Infant leukaemia: Clinical, biological and therapeutic advances

  2006cites this paper
• The challenge of the older patient [Abstract]

  2006cites this paper
• Management of patients with post‐transplant lymphoproliferative disorder: the role of rituximab

  2006cites this paper
• Akute lymphoblastische Leukämien

  2006cites this paper
• Title Improved outcome of acute lymphoblastic leukaemia treated bydelayed intensification in Hong Kong children : HKALL 97 study

  2006cites this paper
• Satellite Symposia and Meet-the-Professor Sessions

  2006cites this paper
• Acute Graft-Versus-Host Disease

  2006cites this paper
• Novel strategies for steroid-refractory acute graft-versus-host disease

  2005cites this paper
• Philadelphia positive acute lymphoblastic leukaemia of childhood

  2005cites this paper
• Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease

  2005cites this paper
• Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial

  2005influential citation
• The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia

  2005cites this paper
• Does a NEAT difference in energy expenditure lead to obesity?

  2005cites this paper
• Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.

  2005cites this paper
• Prognostic Value of Early Response to Treatment Combined with Conventional Risk Factors in Pediatric Acute Lymphoblastic Leukemia

  2005cites this paper
• Re‐immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy

  2005cites this paper
• Could intensified treatment in childhood acute lymphoblastic leukemia improve outcome independently of risk factors?

  2005cites this paper
• Childhood and adolescent lymphoid and myeloid leukemia.

  2004cites this paper
• Association of cytogenetic abnormalities with detection of BCR‐ABL fusion transcripts in children with T‐lineage lymphoproliferative diseases (T‐ALL and T‐NHL)

  2004cites this paper
• RISK ASSESSMENT IN CHILDHOOD AND ADOLESCENT ACUTE LYMPHOBLASTIC LEUKEMIA

  2004cites this paper
• Recent advances in childhood acute lymphoblastic leukemia.

  2004cites this paper
• Chronic graft-versus-host disease: where do we go from here?

  2004cites this paper
• Acute lymphoblastic leukaemia

  2004cites this paper
• Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemia

  2003cites this paper
• The power and perils of prediction.

  2003cites this paper
• Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.

  2003cites this paper
• Newly diagnosed childhood acute lymphoblastic leukemia: update on prognostic factors and treatment

  2003cites this paper
• Prognostic factors in childhood acute lymphoblastic leukemia

  2003cites this paper
• Clinical features of 62 allogeneic stem cell transplantations; the evaluation of prognostic factor in a single institution.

  2003cites this paper
• Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia.

  2003cites this paper
• New treatment strategies in childhood acute lymphoblastic leukaemia.

  2002cites this paper
• Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response

  2002cites this paper